{"id":"W4366160578","doi":"10.1007/s40744-023-00546-0","title":"Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)","year":2023,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Genentech; LG Chem; Sun Pharma; University of British Columbia; Regeneron Pharmaceuticals; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Tolerability; Dosing; Uric acid; Pharmacology; Medicine; Gout; Chemistry; Internal medicine; Adverse effect","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003561666,0.0004051613,0.0008662992,0.0003849133,0.0002503856,0.00003235018,0.0001365867,0.0001923941,0.00003950053],"category_scores_gemma":[0.00004728397,0.0002926394,0.00005053083,0.001238725,0.0002020633,0.0001661078,0.00005958312,0.0003729695,0.00002322759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007331716,"about_ca_system_score_gemma":0.0001579875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001717672,"about_ca_topic_score_gemma":0.00005059089,"domain_scores_codex":[0.9976487,0.0001604485,0.0005345352,0.0006292199,0.0003568602,0.0006702831],"domain_scores_gemma":[0.9988174,0.0001841976,0.0002271373,0.0004444073,0.0001138328,0.0002129606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008854725,0.00560114,0.9725564,0.00005249732,0.0007886451,0.000384717,0.004628895,0.0000474222,0.005461254,0.00005026655,0.00002343725,0.001550626],"study_design_scores_gemma":[0.2155602,0.0185463,0.7480204,0.0005544703,0.0005111441,0.001172538,0.003305359,0.007404076,0.003679707,0.00005992448,0.0001220539,0.001063748],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974796,0.0003880475,0.00003395745,0.0001764506,0.00009225147,0.001567833,0.00001171577,0.0002290374,0.00002110122],"genre_scores_gemma":[0.9992357,0.000125032,0.0002590914,0.0001430814,0.000008552176,0.00006970151,0.00004719114,0.00007546745,0.00003612881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2245359,"threshold_uncertainty_score":0.9999526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03454139405471354,"score_gpt":0.3017176883983055,"score_spread":0.267176294343592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}